Catalyst
Slingshot members are tracking this event:
Rigel (RIGL) Releases Preliminary Phase 2 Data on Fostamatinib in IgA Nephropathy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RIGL |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 05, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Preliminary Data, Fostamatinib, Iga Nephropathy
